Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
WEBSep 30, 2024 · Haleon shares ended trading at 3.929 pounds per share. Pfizer to remain top shareholder in Haleon post sale - LSEG data. Sept 30 (Reuters) - Pfizer's (PFE.N) stake sale in British consumer ...
Pfizer Offloads $3.3 Billion Stake in Sensodyne-Maker Haleon - U.S. News
WEB6 days ago · REUTERS/Dado Ruvic/Illustration/File Photo. (Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest ...
Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon
WEB6 days ago · Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on...
Drug Giant Pfizer Sells $3.3 Billion Stake in Sensodyne-Maker Haleon
WEBSep 30, 2024 · Earlier on Monday a bookrunner said that Pfizer intends to sell about 540 million shares in Haleon, reducing its interest in the Sensodyne maker to 16.2% from 22.6%. Orders below 3.80 pounds per ...
Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn
WEB6 days ago · US drugs giant Pfizer has sold a stake in Sensodyne and Panadol maker Haleon worth around £2.4 billion, cutting its holding from 22% to 15%. Pfizer sold 640 million shares in Haleon for 380p each ...
Pfizer to offload about 6% stake in Sensodyne-maker Haleon, …
WEBSep 30, 2024 · Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) worth of ordinary shares from Pfizer. In March, the U.S. pharma major ...
Pfizer offloads $3.5 billion stake in Sensodyne-maker Haleon
WEBMar 19, 2024 · HLN.L. (Reuters) - Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.5 billion stake in the consumer healthcare firm, bringing down its holding in the British company to...
Pfizer offloads $3.5 bln stake in Sensodyne-maker Haleon
WEBMar 19, 2024 · Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.5 billion stake in the consumer healthcare firm, bringing down its holding in the British company to 22.6%.
Pfizer Offloads $3.5 Billion Stake in Sensodyne-Maker Haleon - U.S. News
WEBMar 19, 2024 · (Reuters) - Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.5 billion stake in the consumer healthcare firm, bringing down its holding in the British company to 22.6%.
Haleon launches with purpose to deliver better everyday health …
WEBWith the demerger from GSK plc (GSK) now complete, maker of Sensodyne, Voltaren and Panadol becomes one of the world’s leading independent consumer health companies. 18 JULY 2022 : Today, Haleon (LSE/NYSE: HLN ) launches as an independent company 100% focused on consumer health, completing its demerger from GSK.